Latanoprost 0.005% Ophthalmic Solution
Latanoprost 0.005% Ophthalmic Solution is a pharmaceutical drug with 15 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
3
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Rocklatan vs Latanoprost Post-DSLT
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
Next Generation Rocklatan
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
Clinical Trials (15)
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Rocklatan vs Latanoprost Post-DSLT
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
Next Generation Rocklatan
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension
Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.
Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated
A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15